|
Volumn 28, Issue 2, 2006, Pages 142-144
|
Clinical analysis of 32 primary intestinal non-Hodgkin's lymphoma
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CHOP PROTOCOL;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
PREDNISONE;
VINCRISTINE;
ADULT;
ARTICLE;
B CELL LYMPHOMA;
CANCER STAGING;
FEMALE;
FOLLOW UP;
HUMAN;
INTESTINE TUMOR;
LARGE CELL LYMPHOMA;
MALE;
MIDDLE AGED;
NONHODGKIN LYMPHOMA;
PATHOLOGY;
PROPORTIONAL HAZARDS MODEL;
REMISSION;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INTESTINAL NEOPLASMS;
LYMPHOMA, B-CELL;
LYMPHOMA, LARGE B-CELL, DIFFUSE;
LYMPHOMA, NON-HODGKIN;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PREDNISONE;
PROPORTIONAL HAZARDS MODELS;
REMISSION INDUCTION;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
VINCRISTINE;
|
EID: 38049092109
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|